Navigation Links
UT Health Science Center researchers study diet and autism
Date:8/7/2008

HOUSTON-(Aug. 7, 2008)Researchers at The University of Texas Health Science Center at Houston have embarked on one of the first double-blind, clinical studies to determine whether gluten and dairy products play a role in autistic behavior as parents have anecdotally claimed.

The pilot study is one of seven current studies on autism in the Department of Pediatrics and the Department of Psychiatry and Behavioral Sciences at The University of Texas Medical School at Houston.

"There's a lot of misinformation, so that's why this study is so important," said Fernando Navarro, M.D., assistant professor of pediatrics at the medical school and lead investigator of the study. "Hundreds and hundreds of parents think this works but we need serious evidence."

Autism is a complex neurobehavioral disorder linked to early abnormalities of brain development. According to the National Institute of Neurological Disorders and Stroke, it affects up to six of every 1,000 children and is characterized by impaired social interaction, problems with verbal and nonverbal communication and unusual, repetitive or severely limited activities and interests. Researchers have discovered that there are differences in the central nervous system's anatomy and function in those diagnosed with autism, but the cause of the disorder is unknown. Experts theorize it may be a combination of genetics and environment.

"A lot of children with autism have gastrointestinal problems such as constipation and diarrhea. Whether these problems are related to brain development is open to question," said Katherine Loveland, Ph.D., co-investigator and professor of psychiatry and behavioral sciences, pediatrics and biomedical sciences at the health science center. "There are neurotransmitters and neuroreceptors in the gut that correspond with those in the brain. There are some scientific reasons to think that some kids may benefit from this diet."

For the double-blind stud
'/>"/>

Contact: Deborah Mann Lake
deborah.m.lake@uth.tmc.edu
713-500-3304
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2

Related biology news :

1. Life Sciences Discovery Fund awards health research project grants
2. Case Western Reserve University study looks at keeping migrant workers children healthy
3. Dartmouth researchers identify an important gene for a healthy, nutritious plant
4. Second Life a first for UH department of health and human performance
5. New study spotlights National Institutes of Health grant outcomes for clinical research
6. Green potato health risk can be eliminated by cutting away affected area
7. New indicator uncovered that can predict coral health
8. UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech
9. EPA releases report on climate change and health
10. Meeting to highlight health impacts of smell and taste
11. Healthy sterols may pose health risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ssociation of Biology Teachers (NABT) will recogni...ciences at Naugatuck Valley Community College (NVC...ion Education Award during the NABT annual profess...mber 2009 in Denver, Colorado. , The Evolution E...itute of Biological Sciences,(AIBS) and Biologica...
(Date:11/5/2009)...versity has been awarded a training grant in the a...tion under its Integrative Graduation Education an...irst IGERT grant to be awarded to Kent State. The ... and Reinvestment Act of 2009, runs through 2014. ...on environment aquatic resource sensing (EARS). Th...
(Date:11/4/2009)... news in natural science) , United States Usin...s water today than it did 35 years ago, despite a ...use are partly attributable to alternative cooling...tion systems. According to the latest USGS water u...ited States goes to cooling thermoelectric power p...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4Taking Aim at Relapse of Leukemia in Kids 49267 1Taking Aim at Relapse of Leukemia in Kids 49267 2
...r deterioration seen in muscular dystrophy can be ...y for their effects against cancer, a Burnham Inst... the potential use of these drugs, called histone ...and repair of dystrophic muscles, thereby counteri...t mouse models of muscular dystrophy. Led by Burnh...
...new project being developed by Central Queensland ... surgery patients around the country could soon ha...t of their own home rather than having to travel t... University’s Rockhampton campus are developing an...ple who have had heart surgery to see if it improv...
...technical advance in the study of the complex rece...researchers at the University of California, San D...the signaling pathways that impact activation of a...ing and to the thrombosis that occurs in heart att...re-build the signaling pathway that regulates acti...
Other Biology News:Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy 2UCSD researchers create roadmap to integrin activation 2UCSD researchers create roadmap to integrin activation 3
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)...wswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulleti...er, President and CEO of Imagenetix, will be prese...RO Conference on Thursday, December 3rd, at 10:30 ...out LD MICRO ,, LD MICRO is a by-invitation onl...ued companies in the micro-cap space. Since 2002, ...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...harmaceuticals,a division of Wyeth (NYSE: WYE ), ...ments with Solvay Pharmaceuticals for the developm... other compounds in earlier,stages of development ...ther psychiatric conditions., Wyeth terminated th...portunity for bifeprunox and determining it would ...
...ng distributor of market,intelligence, MarketResea...hip with Spectra Intelligence which allows for the...ry market analyses through the,MarketResearch.com ...ofessionals throughout the world,easy access to co... from,research publications authored by market exp...
...ex, Inc.,(Nasdaq: MEDX ) announced today that it ...al Group Second Annual SIGnificant Investment Opti...dnesday, March 5, 2008, in New,York. The event wil...estor,Relations section of the Medarex website at ...he presentation will be available following the ev...
Other Biology Technology:Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds 2MarketResearch.com Announces Distribution of Spectra Intelligence Research 2Medarex to Present at the Susquehanna Financial Group Healthcare Conference 2
BMP-2 ELISA Kit from R&D Systems
5x MONO-RABBIT POLY C'GATE DILUENT from AbD Serotec
Argarase from BioVision
SAMPLE DILUENTS BUFFER TRIAL PACK from AbD Serotec
Biology Products: